These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

128 related items for PubMed ID: 16563560

  • 1. Recombinant GM-CSF plus autologous tumor cells as a vaccine for patients with mesothelioma.
    Powell A, Creaney J, Broomfield S, Van Bruggen I, Robinson B.
    Lung Cancer; 2006 May; 52(2):189-97. PubMed ID: 16563560
    [Abstract] [Full Text] [Related]

  • 2. A phase-I trial using a universal GM-CSF-producing and CD40L-expressing bystander cell line (GM.CD40L) in the formulation of autologous tumor cell-based vaccines for cancer patients with stage IV disease.
    Dessureault S, Noyes D, Lee D, Dunn M, Janssen W, Cantor A, Sotomayor E, Messina J, Antonia SJ.
    Ann Surg Oncol; 2007 Feb; 14(2):869-84. PubMed ID: 17103257
    [Abstract] [Full Text] [Related]

  • 3. Induction of immunity to prostate cancer antigens: results of a clinical trial of vaccination with irradiated autologous prostate tumor cells engineered to secrete granulocyte-macrophage colony-stimulating factor using ex vivo gene transfer.
    Simons JW, Mikhak B, Chang JF, DeMarzo AM, Carducci MA, Lim M, Weber CE, Baccala AA, Goemann MA, Clift SM, Ando DG, Levitsky HI, Cohen LK, Sanda MG, Mulligan RC, Partin AW, Carter HB, Piantadosi S, Marshall FF, Nelson WG.
    Cancer Res; 1999 Oct 15; 59(20):5160-8. PubMed ID: 10537292
    [Abstract] [Full Text] [Related]

  • 4. Vaccination with irradiated, autologous melanoma cells engineered to secrete granulocyte-macrophage colony-stimulating factor by adenoviral-mediated gene transfer augments antitumor immunity in patients with metastatic melanoma.
    Soiffer R, Hodi FS, Haluska F, Jung K, Gillessen S, Singer S, Tanabe K, Duda R, Mentzer S, Jaklitsch M, Bueno R, Clift S, Hardy S, Neuberg D, Mulligan R, Webb I, Mihm M, Dranoff G.
    J Clin Oncol; 2003 Sep 01; 21(17):3343-50. PubMed ID: 12947071
    [Abstract] [Full Text] [Related]

  • 5. [Efficacy of autologous renal tumor cell lysate-loaded dendritic cell vaccine in combination with cytokine-induced killer cells on advanced renal cell carcinoma--a report of ten cases].
    Wang H, Zhou FJ, Wang QJ, Qin ZK, Huang LX, Liu ZW, Han H, Li YQ, Chen SP, Xia JC.
    Ai Zheng; 2006 May 01; 25(5):625-30. PubMed ID: 16687087
    [Abstract] [Full Text] [Related]

  • 6. The influence of granulocyte macrophage colony-stimulating factor and prior chemotherapy on the immunological response to a vaccine (ALVAC-CEA B7.1) in patients with metastatic carcinoma.
    von Mehren M, Arlen P, Gulley J, Rogatko A, Cooper HS, Meropol NJ, Alpaugh RK, Davey M, McLaughlin S, Beard MT, Tsang KY, Schlom J, Weiner LM.
    Clin Cancer Res; 2001 May 01; 7(5):1181-91. PubMed ID: 11350882
    [Abstract] [Full Text] [Related]

  • 7. Immunological effects of granulocyte-macrophage colony-stimulating factor and autologous tumor vaccine in patients with renal cell carcinoma.
    Schwaab T, Tretter C, Gibson JJ, Cole BF, Schned AR, Harris R, Wallen EM, Fisher JL, Waugh MG, Truman D, Stempkowski LM, Crosby NA, Heaney J, Ernstoff MS.
    J Urol; 2004 Mar 01; 171(3):1036-42. PubMed ID: 14767265
    [Abstract] [Full Text] [Related]

  • 8. Thoracic stop-flow perfusion in the treatment of refractory malignant pleural mesothelioma: a phase I-II evaluation/trial.
    Guadagni S, Clementi M, Valenti M, Fiorentini G, Cantore M, Kanavos E, Amicucci G.
    In Vivo; 2006 Mar 01; 20(6A):715-8. PubMed ID: 17203752
    [Abstract] [Full Text] [Related]

  • 9. Immunogenicity, including vitiligo, and feasibility of vaccination with autologous GM-CSF-transduced tumor cells in metastatic melanoma patients.
    Luiten RM, Kueter EW, Mooi W, Gallee MP, Rankin EM, Gerritsen WR, Clift SM, Nooijen WJ, Weder P, van de Kasteele WF, Sein J, van den Berk PC, Nieweg OE, Berns AM, Spits H, de Gast GC.
    J Clin Oncol; 2005 Dec 10; 23(35):8978-91. PubMed ID: 16260696
    [Abstract] [Full Text] [Related]

  • 10. High-dose ifosfamide with mesna and granulocyte-colony-stimulating factor (recombinant human G-CSF) in patients with unresectable malignant mesothelioma.
    Talbot SM, Rankin C, Taub RN, Balcerzak SP, Bhoopalam N, Chapman RA, Baker LH, Middleman EL, Antman KH.
    Cancer; 2003 Jul 15; 98(2):331-6. PubMed ID: 12872353
    [Abstract] [Full Text] [Related]

  • 11. Phase I/II trial of an allogeneic cellular immunotherapy in hormone-naïve prostate cancer.
    Simons JW, Carducci MA, Mikhak B, Lim M, Biedrzycki B, Borellini F, Clift SM, Hege KM, Ando DG, Piantadosi S, Mulligan R, Nelson WG.
    Clin Cancer Res; 2006 Jun 01; 12(11 Pt 1):3394-401. PubMed ID: 16740763
    [Abstract] [Full Text] [Related]

  • 12. An open-label, prospective phase I/II study evaluating the immunogenicity and safety of a ras peptide vaccine plus GM-CSF in patients with non-small cell lung cancer.
    Meyer RG, Korn S, Micke P, Becker K, Huber C, Wölfel T, Buhl R.
    Lung Cancer; 2007 Oct 01; 58(1):88-94. PubMed ID: 17599645
    [Abstract] [Full Text] [Related]

  • 13. Autologous tumor vaccine lowering postsurgical recurrent rate of hepatocellular carcinoma.
    Peng B, Liang L, Chen Z, He Q, Kuang M, Zhou F, Lu M, Huang J.
    Hepatogastroenterology; 2006 Oct 01; 53(69):409-14. PubMed ID: 16795983
    [Abstract] [Full Text] [Related]

  • 14. Autologous tumor cell vaccination plus infusion of GM-CSF by a programmable pump in the treatment of recurrent malignant gliomas.
    Clavreul A, Piard N, Tanguy JY, Gamelin E, Rousselet MC, Leynia P, Menei P.
    J Clin Neurosci; 2010 Jul 01; 17(7):842-8. PubMed ID: 20466548
    [Abstract] [Full Text] [Related]

  • 15. Phase II trial of B7-1 (CD-86) transduced, cultured autologous tumor cell vaccine plus subcutaneous interleukin-2 for treatment of stage IV renal cell carcinoma.
    Fishman M, Hunter TB, Soliman H, Thompson P, Dunn M, Smilee R, Farmelo MJ, Noyes DR, Mahany JJ, Lee JH, Cantor A, Messina J, Seigne J, Pow-Sang J, Janssen W, Antonia SJ.
    J Immunother; 2008 Jan 01; 31(1):72-80. PubMed ID: 18157014
    [Abstract] [Full Text] [Related]

  • 16. Overlapping human leukocyte antigen class I/II binding peptide vaccine for the treatment of patients with stage IV melanoma: evidence of systemic immune dysfunction.
    Melanoma Study Group of the Mayo Clinic Cancer CenterMayo Clinic Cancer Center, Rochester, Minnesota 55905, USA. markovic.svetomir@mayo.edu, Celis E.
    Cancer; 2007 Jul 01; 110(1):203-14. PubMed ID: 17541944
    [Abstract] [Full Text] [Related]

  • 17. Dendritic cells loaded with killed allogeneic melanoma cells can induce objective clinical responses and MART-1 specific CD8+ T-cell immunity.
    Palucka AK, Ueno H, Connolly J, Kerneis-Norvell F, Blanck JP, Johnston DA, Fay J, Banchereau J.
    J Immunother; 2006 Jul 01; 29(5):545-57. PubMed ID: 16971810
    [Abstract] [Full Text] [Related]

  • 18. Phase I study of sequential vaccinations with fowlpox-CEA(6D)-TRICOM alone and sequentially with vaccinia-CEA(6D)-TRICOM, with and without granulocyte-macrophage colony-stimulating factor, in patients with carcinoembryonic antigen-expressing carcinomas.
    Marshall JL, Gulley JL, Arlen PM, Beetham PK, Tsang KY, Slack R, Hodge JW, Doren S, Grosenbach DW, Hwang J, Fox E, Odogwu L, Park S, Panicali D, Schlom J.
    J Clin Oncol; 2005 Feb 01; 23(4):720-31. PubMed ID: 15613691
    [Abstract] [Full Text] [Related]

  • 19. Recombinant human granulocyte-macrophage colony-stimulating factor (GM-CSF, sargramostim) administered for 3 years as adjuvant therapy of stages II(T4), III, and IV melanoma.
    Spitler LE, Weber RW, Allen RE, Meyer J, Cruickshank S, Garbe E, Lin HY, Soong SJ.
    J Immunother; 2009 Feb 01; 32(6):632-7. PubMed ID: 19483646
    [Abstract] [Full Text] [Related]

  • 20. Consolidative dendritic cell-based immunotherapy elicits cytotoxicity against malignant mesothelioma.
    Hegmans JP, Veltman JD, Lambers ME, de Vries IJ, Figdor CG, Hendriks RW, Hoogsteden HC, Lambrecht BN, Aerts JG.
    Am J Respir Crit Care Med; 2010 Jun 15; 181(12):1383-90. PubMed ID: 20167848
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.